Woo advises on equity and debt capital markets transactions, including initial public offerings, share placings, rights offerings, bond offerings and other corporate compliance work associated with the Hong Kong Stock Exchange.
She joined Shearman & Sterling in 2011 and has advised on several initial public offerings in Hong Kong by Chinese companies, such as contract drug manufacturer WuXi Biologics (Cayman) Inc.’s $510 million listing last year.
Before Shearman & Sterling, Woo was at Linklaters, having joined as a paralegal in 2005. She qualified in 2010 and then became an associate at the Magic Circle firm.
Woo is the latest in a string of associates to join Kirkland & Ellis as a partner in Hong Kong. Earlier this year, Kirkland recruited Ram Narayan as a corporate partner from Sullivan & Cromwell. He was part of the team that advised Chinese e-commerce giant Alibaba Group Holding Ltd. on a $1 billion investment in Southeast Asian peer Lazada Group in 2017.
And late last year, Kirkland recruited former Davis Polk & Wardwell associate Meng Ding as a securities partner. Ding has over the years advised on some high-profile initial public offerings by Chinese companies, including the Agricultural Bank of China’s $22 billion listing in 2010.
Although Kirkland & Ellis has been actively recruiting partners in recent months, it also has experienced some defections in Hong Kong. Securities partner Benjamin Su, for example, left Kirkland to rejoin his former firm—Latham & Watkins—in February.